# Zenpep

NDC: 73562-111
Generic name: pancrelipase lipase, pancrelipase protease, pancrelipase amylase
Labeler / Manufacturer: Aimmune Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20201201

FDA application: BLA022210

## Active ingredients

- PANCRELIPASE AMYLASE: 63000 [USP'U]/1
- PANCRELIPASE LIPASE: 15000 [USP'U]/1
- PANCRELIPASE PROTEASE: 47000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73562-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73562-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f16f2d4-8df6-4bd7-ac10-56994fa257b0